DIGITAL EDITION

ARCHIVES

Category: Past Articles

Editorial Message and Issue Highlights–Vol. 17, No. 1–3, January–March 2020

Dear Colleagues: Welcome to the January–March 2020 edition of Innovations in Clinical Neuroscience (ICNS). I’d first like to inform our readers that starting this year, ICNS will move from a

Subependymal Giant-cell Astrocytoma Masquerading as Restrictive Eating Disorder and Depression in an Adolescent

by Alicia Barnes, DO, MPH; Maggie M. Wang, BS; Jordan Feltes, BS; Je Ko, MD, PhD; and Miguel A. Guzman, MD Drs. Barnes and Ko are with the Department of

Innovative Approaches for Slowing Disease Progression in Parkinson’s Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting

by Monica Javidnia, PhD; Mark Frasier, PhD; Ira Shoulson, MD; Ibrahim Turkoz, PhD; and Kumar Budur, MD, MS Drs. Javidnia and Shoulson are with the Center for Health + Technology

Donkey Therapy and Hippotherapy: Two Faces of the Same Coin?

by Simona Portaro, MD, PhD; Giuseppa Maresca, PsyD; Antonio Raffa, MSc; Gaetano Gemelli; Barbara Aliberti; and Rocco Salvatore Calabrò, MD, PhD Dr. Portaro, Dr. Maresca, Mr. Raffa, and Dr. Calabrò

Psychiatric Symptoms in Cushing’s Syndrome: A Systematic Review

by Tiffany Y. Lin, MD; Jasmine Hanna; and Waguih William IsHak, MD, FAPA Drs. Lin and Ishak are with the David Geffen School of Medicine at UCLA in Los Angeles,

Navigating the ADA: What Clinicians Need to Know—Part Two

by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Vice President of Risk Management at Professional Risk Management Services in Arlington, Virginia. FUNDING: No funding was provided for the preparation

Letter to the Editor: Role of Horse-assisted Therapy in the Rehabilitation Field: Past, Present, and Future Perspectives

Dear Editor: Central and peripheral nervous system lesions might induce paralysis, weakness, and/or loss of dexterity, which are the main target of rehabilitative interventions.1 In fact, a specific training with

Editorial Message and Issue Highlights–Vol. 16, No. 11–12, November-December 2019

Dear Colleagues: Welcome to the November–December 2019 edition of Innovations in Clinical Neuroscience (ICNS). The issue begins with a case report by Diaz et al titled, “Use of Noninvasive Ventilation

Improving Depression Management in Patients with Medical Illness Using Collaborative Care: Linking Treatment from the Inpatient to the Outpatient Setting

by Gabriel Edwards, MD, MPH; Teryl Nuckols, MD, MSHS; Nathalie Herrera, MD; Itai Danovitch, MD, MBA; and Waguih William IsHak, MD, FAPA Drs. Edwards, Herrera, Danovitch, and IsHak are with

A Look at Genetic Linkage between Clozapine-induced Agranulocytosis, Malignant Hyperthermia, Neuroleptic Malignant Syndrome, and Statin-induced Myopathy

by Nitin Pothen, MD; Shveta Kansal, MD; Theodor Rais, MD; Stacy Doumas, MD; and Ramon Solhkhah, MD Dr. Pothen and Dr. Kansal are with Ocean Medical Center, Hackensack Meridian Health

Use of Brexanolone for Postpartum Depression

by Jonathan R. Scarff, MD Dr. Scarff is with the Behavioral Health Service Line, Kenner Army Health Clinic, in Fort Lee, Virginia. Funding: No funding was provided. Disclosures: Disclaimer: The

Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain—Part II

by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada Kasaraneni, MBBS; Christiane S. Hampe, PhD; and Anita H. Clayton, MD Dr. Yarlagadda is with the Department of Defense and

Navigating the ADA: What Clinicians Need to Know—Part One

by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Vice President of Risk Management at Professional Risk Management Services in Arlington, Virginia. Funding: No funding was provided for the preparation